olescence and is more likely to persist after parathyroid-ectomy than in adults. Cinacalcet HCl is a new calcimi-metic that has been used successfully for the treatment of primary and secondary hyperparathyroidism in adults, but its use in adolescents has not been reported. Case: A 16 year-old male presented with hypercalcemia that had persisted for 1.5 years after parathyroidectomy for primary hyperparathyroidism. Parathyroid hormone (PTH) concentrations were nonsupressed despite a mean (SD) serum calcium concentration of 2.82 (0.06) mmol/L. Treatment with cinacalcet HCl was initiated and a pharmacodynamic profile was obtained for serum calcium, phosphorus, and PTH. Cinacalcet HCl normal-ized serum calcium. The changes in PTH were assay de...
Cinacalcet, a calcimimetic, was evaluated in persistent hyperparathyroidism after kidney transplanta...
Introduction: Neonatal severe hyperparathyroidism (NSHPT) is a rare cause of neonatal hypercalcemia ...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
Cinacalcet is a type II calcimimetic agent which is an allosteric modulator of the calcium-sensing r...
Two pediatric patients with different causes of hyperparathyroidism are reported. First patient is a...
Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiv...
Familial benign hypocalciuric hypercalcaemia (FHH) results from a heterozygous inactivating mutation...
Copyright © 2014 D. Grove-Laugesen and L. Rejnmark. This is an open access article distributed under...
Persistent hyperparathyroidism (HPT) after kidney transplantation (KTx) is associated with hypercalc...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
An underrecognized side effect of long-term lithium carbonate therapy is hyperparathyroidism with as...
A 77-year-old man was referred to our department for surgical treatment of a right ureteral stone id...
Primary hyperparathyroidism (PHPT) is the most common etiology of hypercalcemia in the ambulatory se...
BACKGROUND: Current treatments for hypercalcemia caused by lung cell carcinomas producing parathyroi...
Cinacalcet, a calcimimetic, was evaluated in persistent hyperparathyroidism after kidney transplanta...
Introduction: Neonatal severe hyperparathyroidism (NSHPT) is a rare cause of neonatal hypercalcemia ...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
Cinacalcet is a type II calcimimetic agent which is an allosteric modulator of the calcium-sensing r...
Two pediatric patients with different causes of hyperparathyroidism are reported. First patient is a...
Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiv...
Familial benign hypocalciuric hypercalcaemia (FHH) results from a heterozygous inactivating mutation...
Copyright © 2014 D. Grove-Laugesen and L. Rejnmark. This is an open access article distributed under...
Persistent hyperparathyroidism (HPT) after kidney transplantation (KTx) is associated with hypercalc...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
An underrecognized side effect of long-term lithium carbonate therapy is hyperparathyroidism with as...
A 77-year-old man was referred to our department for surgical treatment of a right ureteral stone id...
Primary hyperparathyroidism (PHPT) is the most common etiology of hypercalcemia in the ambulatory se...
BACKGROUND: Current treatments for hypercalcemia caused by lung cell carcinomas producing parathyroi...
Cinacalcet, a calcimimetic, was evaluated in persistent hyperparathyroidism after kidney transplanta...
Introduction: Neonatal severe hyperparathyroidism (NSHPT) is a rare cause of neonatal hypercalcemia ...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...